chloroquine and GS-441524

chloroquine has been researched along with GS-441524 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Barreca, ML; Cecchetti, V; Cernicchi, G; Corona, A; De Jonghe, S; Esposito, F; Felicetti, T; Jochmans, D; Manfroni, G; Massari, S; Milia, J; Neyts, J; Nizi, MG; Persoons, L; Sabatini, S; Schols, D; Tabarrini, O; Tramontano, E; Vangeel, L1
Brügel, M; Habler, K; Liebchen, U; Paal, M; Scharf, C; Schönermarck, U; Teupser, D; Vogeser, M1

Other Studies

2 other study(ies) available for chloroquine and GS-441524

ArticleYear
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity.
    ACS medicinal chemistry letters, 2022, May-12, Volume: 13, Issue:5

    Topics:

2022
Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum
    Journal of pharmaceutical and biomedical analysis, 2021, Mar-20, Volume: 196

    Topics: Adenosine; Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Azithromycin; Chloroquine; Chromatography, Liquid; COVID-19; COVID-19 Drug Treatment; Furans; Humans; Hydroxychloroquine; Isotopes; Lopinavir; Pandemics; Pyrazines; Pyrroles; Ritonavir; SARS-CoV-2; Tandem Mass Spectrometry; Triazines

2021